The Color of COVID: Will Vaccine Trials Reflect America’s Diversity? | Kaiser Health News: Although racial minorities, older people and those with underlying medical conditions are most at risk from COVID-19, they’ve historically been the least likely to be included in clinical trials for treatments for serious diseases. Will that change with COVID-19?
No comments:
Post a Comment